oroxine 200 mikrog tabletti
aspen pharma trading limited - levothyroxinum natricum pentahydricum - tabletti - 200 mikrog - levotyroksiininatrium
digoxin orion mite 0.0625 mg tabletti
aspen pharma trading limited - digoxin - tabletti - 0.0625 mg - digoksiini
digoxin orion semi 0.125 mg tabletti
aspen pharma trading limited - digoxin - tabletti - 0.125 mg - digoksiini
digoxin orion 0.25 mg tabletti
aspen pharma trading limited - digoxin - tabletti - 0.25 mg - digoksiini
gonazon
intervet international bv - atsaglynafareliini - aivolisäkkeen ja hypotalamuksen hormonit ja analogit - dogs; salmonidae (salmonid fish) - naisten lohikalojen, kuten atlantin lohi (salmo salar), kirjolohi (oncorhynchus mykiss), taimen (salmo trutta) ja nieriä (salvelinus alpinus)induktio ja synkronointi ovulaation tuotantoon silmät-munat ja paista. koiria (narttuja)ehkäisy sukurauhastoiminnan nartuilla kautta pitkällä aikavälillä saarto gonadotropiinin synteesi.
nucala
glaxosmithkline trading services - mepolizumab - astma - obstruktiivisten hengitystiesairauksien lääkkeet, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.
rolufta ellipta (previously rolufta)
glaxosmithkline trading services limited - umeklidiniumbromidia - keuhkosairaus, krooninen obstruktiivinen - obstruktiivisten hengitystiesairauksien lääkkeet, - rolufta on merkitty hoito-bronkodilataattorikäsittelyksi oireiden lievittämiseksi aikuispotilailla, joilla on krooninen obstruktiivinen keuhkosairaus (copd).
zyloric 100 mg tabletti
aspen pharma trading limited - allopurinol - tabletti - 100 mg - allopurinoli
imurel 50 mg tabletti, kalvopäällysteinen
aspen pharma trading limited - azathioprine - tabletti, kalvopäällysteinen - 50 mg - atsatiopriini
oradexon 5 mg/ml injektioneste, liuos
aspen pharma trading limited - dexamethasone sodium phosphate - injektioneste, liuos - 5 mg/ml - deksametasoni